impact factor, citescore
logo
 

Letters to the Editor

 

Frequency and severity of COVID-19 in patients treated with biological disease-modifying anti-rheumatic drugs for inflammatory rheumatic disease: a cross-sectional study


1, 2, 3, 4, 5, 6, 7, 8

 

  1. Department of Rheumatology, Nord Franche-Comté Hospital, Belfort, France.
  2. Department of Rheumatology, Nord Franche-Comté Hospital, Belfort, France.
  3. Department of Rheumatology, Nord Franche-Comté Hospital, Belfort, France.
  4. Department of Rheumatology, Nord Franche-Comté Hospital, Belfort, France.
  5. Department of Rheumatology, Nord Franche-Comté Hospital, Belfort, France.
  6. Clinical Research Unit, Nord Franche-Comté Hospital, Belfort, France.
  7. Department of Rheumatology, Nord Franche-Comté Hospital, Belfort, France.
  8. Department of Rheumatology and Clinical Research Unit, Nord Franche-Comté Hospital, Belfort, France. thierry.conrozier@hnfc.fr

CER13973
2020 Vol.38, N°6
PI 1273
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 33253100 [PubMed]

Received: 25/08/2020
Accepted : 19/10/2020
In Press: 22/11/2020
Published: 03/12/2020

Rheumatology Article